THE CONSTRUCT (20-275) WAS EXPRESSED WITH A PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS ...THE CONSTRUCT (20-275) WAS EXPRESSED WITH A PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE.
解像度: 2.39→39.676 Å / Num. obs: 13045 / % possible obs: 99.3 % / Observed criterion σ(I): -3 / Biso Wilson estimate: 49.602 Å2 / Rmerge(I) obs: 0.077 / Net I/σ(I): 13.27
反射 シェル
Diffraction-ID: 1
解像度 (Å)
最高解像度 (Å)
Rmerge F obs
Rmerge(I) obs
Mean I/σ(I) obs
Num. measured obs
Num. possible
Num. unique obs
Rrim(I) all
% possible all
2.39-2.48
0.842
0.606
2.4
6496
1346
1345
0.68
99.9
2.48-2.57
0.914
0.482
3
5661
1146
1145
0.539
99.9
2.57-2.69
0.933
0.369
3.8
6400
1335
1334
0.415
99.9
2.69-2.83
0.96
0.278
5.3
6227
1278
1276
0.312
99.8
2.83-3.01
0.979
0.191
7.3
6258
1303
1303
0.215
100
3.01-3.24
0.993
0.117
11.2
6113
1280
1279
0.131
99.9
3.24-3.57
0.997
0.077
16.3
6205
1329
1317
0.086
99.1
3.57-4.08
0.997
0.054
22.8
5662
1293
1231
0.062
95.2
4.08-5.12
0.999
0.04
27.9
6191
1330
1328
0.045
99.8
5.12
0.999
0.037
30.1
6298
1466
1452
0.042
99
-
位相決定
位相決定
手法: 多波長異常分散
-
解析
ソフトウェア
名称
バージョン
分類
NB
MolProbity
3beta29
モデル構築
PDB_EXTRACT
3.1
データ抽出
SHELX
位相決定
SHARP
位相決定
XSCALE
データスケーリング
BUSTER-TNT
2.10.0
精密化
XDS
データ削減
SHELXD
位相決定
BUSTER
2.10.0
精密化
精密化
構造決定の手法: 多波長異常分散 / 解像度: 2.39→39.676 Å / Cor.coef. Fo:Fc: 0.9456 / Cor.coef. Fo:Fc free: 0.9031 / Occupancy max: 1 / Occupancy min: 0.15 / 交差検証法: THROUGHOUT / σ(F): 0 詳細: 1. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 FOR THE REDUCED ...詳細: 1. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET INCORPORATION. 2. ATOM RECORD CONTAINS SUM OF TLS AND RESIDUAL B FACTORS. ANISOU RECORD CONTAINS SUM OF TLS AND RESIDUAL U FACTORS. 3. THE EXPERIMENTAL (MAD) PHASES WERE USED AS RESTRAINTS DURING REFINEMENT. 4. NITRATE (NO3) AND PEG FRAGMENTS (PEG) FROM THE CRYSTALLIZATION SOLUTION AND 1,2-ETHANEDIOL (EDO) FROM THE CRYOPROTECTANT SOLUTION HAVE BEEN MODELED IN THE SOLVENT STRUCTURE.